Back to Search
Start Over
Everest Medicines collaborates with Kezar Life Sciences to develop and commercialize zetomipzomib in Greater China and other Asian markets
- Source :
- PharmaBiz. September 22, 2023
- Publication Year :
- 2023
-
Abstract
- Everest Medicines, a biopharmaceutical company, announced it has entered into a collaboration and license agreement with Kezar Life Sciences (Kezar), a clinical-stage biotechnology company, to develop and commercialize Kezar's lead [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PharmaBiz
- Publication Type :
- Periodical
- Accession number :
- edsgcl.766208279